Literature DB >> 3025911

Effector systems coupled to serotonin receptors in brain: serotonin stimulated phosphoinositide hydrolysis.

E Sanders-Bush, P J Conn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025911

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


× No keyword cloud information.
  6 in total

1.  A 5-HT(2C) receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference.

Authors:  John D McCorvy; Aubrie A Harland; Rebecca Maglathlin; David E Nichols
Journal:  Neurosci Lett       Date:  2011-07-30       Impact factor: 3.046

2.  Adaptive changes in the reactivity of 5-HT1A and 5-HT2 receptors induced in rat frontal cortex by repeated imipramine and citalopram.

Authors:  Bartosz Bobula; Krzysztof Tokarski; Agnieszka Zahorodna; Grzegorz Hess
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-17       Impact factor: 3.000

3.  5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites.

Authors:  R L Jakab; P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

Review 4.  A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action.

Authors:  G J Marek; C J McDougle; L H Price; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia.

Authors:  David A Martin; Danuta Marona-Lewicka; David E Nichols; Charles D Nichols
Journal:  Neuropharmacology       Date:  2014-04-03       Impact factor: 5.250

6.  Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.

Authors:  M Titeler; R A Lyon; R A Glennon
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.